Literature DB >> 12368238

Mammalian retroelements.

Prescott L Deininger1, Mark A Batzer.   

Abstract

The eukaryotic genome has undergone a series of epidemics of amplification of mobile elements that have resulted in most eukaryotic genomes containing much more of this 'junk' DNA than actual coding DNA. The majority of these elements utilize an RNA intermediate and are termed retroelements. Most of these retroelements appear to amplify in evolutionary waves that insert in the genome and then gradually diverge. In humans, almost half of the genome is recognizably derived from retroelements, with the two elements that are currently actively amplifying, L1 and Alu, making up about 25% of the genome and contributing extensively to disease. The mechanisms of this amplification process are beginning to be understood, although there are still more questions than answers. Insertion of new retroelements may directly damage the genome, and the presence of multiple copies of these elements throughout the genome has longer-term influences on recombination events in the genome and more subtle influences on gene expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368238     DOI: 10.1101/gr.282402

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  169 in total

1.  Analysis of primate genomic variation reveals a repeat-driven expansion of the human genome.

Authors:  Ge Liu; Shaying Zhao; Jeffrey A Bailey; S Cenk Sahinalp; Can Alkan; Eray Tuzun; Eric D Green; Evan E Eichler
Journal:  Genome Res       Date:  2003-03       Impact factor: 9.043

2.  Highly abundant pea LTR retrotransposon Ogre is constitutively transcribed and partially spliced.

Authors:  Pavel Neumann; Dana Pozárková; Jirí Macas
Journal:  Plant Mol Biol       Date:  2003-10       Impact factor: 4.076

3.  Nucleolar clustering of dispersed tRNA genes.

Authors:  Martin Thompson; Rebecca A Haeusler; Paul D Good; David R Engelke
Journal:  Science       Date:  2003-11-21       Impact factor: 47.728

4.  Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.

Authors:  Yutaka Suzuki; Riu Yamashita; Matsuyuki Shirota; Yuta Sakakibara; Joe Chiba; Junko Mizushima-Sugano; Kenta Nakai; Sumio Sugano
Journal:  Genome Res       Date:  2004-09       Impact factor: 9.043

5.  Independently derived targeting of 28S rDNA by A- and D-clade R2 retrotransposons: Plasticity of integration mechanism.

Authors:  Blaine K Thompson; Shawn M Christensen
Journal:  Mob Genet Elements       Date:  2011-05

6.  Locus- and domain-dependent control of DNA methylation at mouse B1 retrotransposons during male germ cell development.

Authors:  Kenji Ichiyanagi; Yufeng Li; Yungfeng Li; Toshiaki Watanabe; Tomoko Ichiyanagi; Kei Fukuda; Junko Kitayama; Yasuhiro Yamamoto; Satomi Kuramochi-Miyagawa; Toru Nakano; Yukihiro Yabuta; Yoshiyuki Seki; Mitinori Saitou; Hiroyuki Sasaki
Journal:  Genome Res       Date:  2011-10-31       Impact factor: 9.043

Review 7.  A LINE-1 component to human aging: do LINE elements exact a longevity cost for evolutionary advantage?

Authors:  Georges St Laurent; Neil Hammell; Timothy A McCaffrey
Journal:  Mech Ageing Dev       Date:  2010-03-25       Impact factor: 5.432

8.  Large inverted repeats within Xp11.2 are present at the breakpoints of isodicentric X chromosomes in Turner syndrome.

Authors:  Stuart A Scott; Ninette Cohen; Tracy Brandt; Peter E Warburton; Lisa Edelmann
Journal:  Hum Mol Genet       Date:  2010-06-22       Impact factor: 6.150

9.  Transcription of a donor enhances its use during double-strand break-induced gene conversion in human cells.

Authors:  Ezra Schildkraut; Cheryl A Miller; Jac A Nickoloff
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

10.  Local mutagenic impact of insertions of LTR retrotransposons on the mouse genome.

Authors:  Erick Desmarais; Khalid Belkhir; John Carlos Garza; François Bonhomme
Journal:  J Mol Evol       Date:  2006-10-29       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.